课题基金 / 基金详情

项目摘要

项目成果

Krystof S Bankiewicz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): To advance neurological gene therapy applications into the clinic there is an urgent need to improve our understanding of gene delivery vectors, with particular emphasis on distribution and safety after direct brain delivery. While AAV2 currently dominates clinical development, alternative AAV serotypes may be better suited for some applications. The recent game-changing development of image-guided delivery techniques provides opportunity to accurately compare different vectors after direct brain delivery. Accordingly we aim to investigate the distribution and immune responses of 5 AAV serotypes (AAV1, 2, 5, 8 and 9) after confined delivery to grey or white matter structures in the non-human primate (NHP) brain. This in-depth assessment of AAV vectors will provide investigators with scientific rational for selecting a specific vector for a particular neurological application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of a single-pass surgical trajectory to enable AAV2-hAADC infusion into brainstem and mid-brain in nonhuman primate
  • 批准号:
    10040048
  • 项目类别:
  • 资助金额:
    $42.9万
  • 财政年份:
    2020
  • 负责人:
    Krystof S Bankiewicz
  • 依托单位:
Development of a nanoparticle-based gene editing technology for neurological applications
  • 批准号:
    10012948
  • 项目类别:
  • 资助金额:
    $78.26万
  • 财政年份:
    2019
  • 负责人:
    Krystof S Bankiewicz
  • 依托单位:
Development of a Nanoparticle-Based Gene Editing Technology for Neurological Applications
  • 批准号:
    10263159
  • 项目类别:
  • 资助金额:
    $78.28万
  • 财政年份:
    2019
  • 负责人:
    Krystof S Bankiewicz
  • 依托单位:
Development of a nanoparticle-based gene editing technology for neurological applications
  • 批准号:
    9810326
  • 项目类别:
  • 资助金额:
    $77.93万
  • 财政年份:
    2019
  • 负责人:
    Krystof S Bankiewicz
  • 依托单位:
海外基金